A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis.

iScience · 2023 · PMC10481358 · PMID 37680472

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a statistical trendno p-value reported

A statistical trend was found for the forced vital capacity (FVC) to increase among patients treated with bermekimab (5 out of 10 patients compared to 2 out of 10 treated with placebo; p: 0.054 by the binomial test).

also in 1,573 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.